Scancell Stock Price, News & Analysis (LON:SCLP)

GBX 10.73 -0.02 (-0.19 %)
(As of 01/18/2018 06:43 AM ET)
Previous CloseGBX 10.75
Today's RangeGBX 10.50 - GBX 10.73
52-Week RangeGBX 0.11 - GBX 16
Volume114,343 shs
Average Volume154,628 shs
Market Capitalization£31.56 million
P/E Ratio-1,073.00
Dividend YieldN/A
BetaN/A

About Scancell (LON:SCLP)

Scancell logoScancell Holdings plc is a biopharmaceutical company focused on the cancer therapeutics market. The Company's principal activity consists of the discovery and development of monoclonal antibodies and vaccines for the treatment of cancer. The Company is developing a pipeline of immunotherapies for the treatment of cancer based on its ImmunoBody and Moditope platforms. The Company's products include SCIB1, SCIB2 and Modi-1. The Company's first cancer vaccine, SCIB1, is being developed for the treatment of melanoma and is in Phase I/II clinical trials. SCIB2 contains multiple T cell epitopes derived from the lung cancer associated antigen NY-ESO-1. It is developed to the point at which the product is defined and ready for further preclinical development as an immunotherapy for any tumor that expresses the NY-ESO-1 antigen. The Company's first Moditope development candidate is Modi-1. Modi-1 consists of two citrullinated vimentin peptides and one citrullinated enolase peptide.

Receive SCLP News and Ratings via Email

Sign-up to receive the latest news and ratings for SCLP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorBiotechnology & Medical Research - NEC
SymbolLON:SCLP
CUSIPN/A
Phone+44-115-8231863

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-1073
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSGBX (0.01)
Net IncomeN/A
Net MarginsN/A
Return on Equity-49.20%
Return on Assets-45.76%

Miscellaneous

EmployeesN/A
Outstanding Shares312,060,000

Scancell (LON:SCLP) Frequently Asked Questions

What is Scancell's stock symbol?

Scancell trades on the London Stock Exchange (LON) under the ticker symbol "SCLP."

Where is Scancell's stock going? Where will Scancell's stock price be in 2018?

1 brokers have issued 1-year price targets for Scancell's stock. Their predictions range from GBX 68 to GBX 68. On average, they expect Scancell's stock price to reach GBX 68 in the next year. View Analyst Ratings for Scancell.

Who are some of Scancell's key competitors?

Who are Scancell's key executives?

Scancell's management team includes the folowing people:

  • Richard Morley Goodfellow Ph.D., Executive Director
  • Lindy Gillian Durrant, Chief Scientific Officer, Executive Director
  • Sally Elizabeth Adams, Development Director, Director (Age 54)
  • John C. Chiplin Ph.D., Non-Executive Chairman of the Board (Age 57)
  • Katherine Cornish-Bowden, Non-Executive Director (Age 44)
  • Matthew G.W. Frohn, Non-Executive Director
  • Alan James Lewis Ph.D., Non-Executive Director (Age 71)

How do I buy Scancell stock?

Shares of Scancell and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Scancell's stock price today?

One share of Scancell stock can currently be purchased for approximately GBX 10.73.

How big of a company is Scancell?

Scancell has a market capitalization of £31.56 million.

How can I contact Scancell?

Scancell's mailing address is Department of Clinical Oncology Hucknall Road, NOTTINGHAM, NG5 1PB, United Kingdom. The company can be reached via phone at +44-115-8231863.


MarketBeat Community Rating for Scancell (SCLP)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  121 (Vote Outperform)
Underperform Votes:  64 (Vote Underperform)
Total Votes:  185
MarketBeat's community ratings are surveys of what our community members think about Scancell and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Scancell (LON:SCLP) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 68GBX 68GBX 68GBX 68

Scancell (LON:SCLP) Consensus Price Target History

Price Target History for Scancell (LON:SCLP)

Scancell (LON:SCLP) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
7/11/2017Panmure GordonReiterated RatingBuyGBX 68View Rating Details
(Data available from 1/18/2016 forward)

Earnings

Earnings History for Scancell (LON:SCLP)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Scancell (LON:SCLP) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Scancell (LON:SCLP)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Scancell (LON SCLP)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Scancell (LON SCLP) News Headlines

Source:
DateHeadline
Should You Be Concerned About Scancell Holdings plc’s (LON:SCLP) Investors?Should You Be Concerned About Scancell Holdings plc’s (LON:SCLP) Investors?
finance.yahoo.com - January 4 at 11:11 AM
Is Scancell Holdings plc (AIM:SCLP) Cheap And High Growth?Is Scancell Holdings plc (AIM:SCLP) Cheap And High Growth?
finance.yahoo.com - November 18 at 11:46 AM
SCLP: A Vanguard in Cancer Vaccines: 2 Platforms, 3 Products, 5 IndicationsSCLP: A Vanguard in Cancer Vaccines: 2 Platforms, 3 Products, 5 Indications
finance.yahoo.com - October 6 at 9:01 AM
Scancell’s (SCLP.L )Addario Lung Cancer CollaborationScancell’s (SCLP.L )Addario Lung Cancer Collaboration
finance.yahoo.com - October 6 at 9:01 AM
Scancell Holdings Share ChatScancell Holdings Share Chat
www.lse.co.uk - July 16 at 8:02 PM
Half Year 2017 Scancell Holdings PLC Earnings Release - Before Market OpenHalf Year 2017 Scancell Holdings PLC Earnings Release - Before Market Open
biz.yahoo.com - January 31 at 10:43 PM
Scancell Holdings Regulatory NewsScancell Holdings Regulatory News
www.lse.co.uk - January 3 at 9:46 AM
Results of AGM - London South East (registration) (blog)Results of AGM - London South East (registration) (blog)
www.lse.co.uk - October 18 at 7:04 PM

SEC Filings

Scancell (LON:SCLP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Scancell (LON SCLP) Stock Chart for Thursday, January, 18, 2018

Loading chart…

This page was last updated on 1/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.